Dapagliflozin (10mg) & GLIDAPAFLOZIN 10 Tablet - Steris Healthcare PVT LTD………
May 14, 2024
Introduction
GLIDAPAFLOZIN 10 is a once-daily oral antidiabetic tablet containing Dapagliflozin 10 mg, a highly selective Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor. It is used to improve glycemic control in adults with Type 2 Diabetes Mellitus (T2DM) and is also proven to provide cardiovascular and renal benefits beyond glycemic control.This tablet can be used as monotherapy or in combination with metformin, DPP-4 inhibitors, insulin, or other oral antidiabetics depending on individual patient requirements.
Composition
Each film-coated tablet contains:
-
Dapagliflozin – 10 mg
Mechanism of Action
Dapagliflozin acts by:
-
Inhibiting SGLT2 transporters in the proximal renal tubules
-
Preventing reabsorption of filtered glucose into the bloodstream
-
Promoting urinary glucose excretion, which leads to lower blood glucose levels
-
Working independent of insulin, making it effective even in insulin resistance
-
Providing modest weight loss and blood pressure reduction
Therapeutic Indications
GLIDAPAFLOZIN 10 is indicated for:
-
Type 2 Diabetes Mellitus (T2DM) in adults to improve glycemic control
-
Patients at high cardiovascular risk
-
Heart failure with reduced ejection fraction (HFrEF)
-
Chronic kidney disease (CKD) (with or without diabetes)
Clinical Benefits
Clinical Benefit | Explanation |
---|---|
HbA1c Reduction | Average reduction of 0.5% to 1% |
Weight Loss | Due to calorie loss in urine |
BP Reduction | Mild systolic BP drop (2-5 mmHg) |
Heart Failure Benefit | Reduced hospitalization risk |
Renal Protection | Slows CKD progression |
Dosage and Administration
Parameter | Details |
---|---|
Dose | 10 mg once daily |
Route | Oral |
Timing | Can be taken with or without food |
Swallow whole | Do not crush or split |
Renal dosing:
-
Not recommended in eGFR < 25 mL/min/1.73m²
-
Continue cautiously in moderate CKD (eGFR ≥25) with nephrologist advice
Side Effects of Dapagliflozin 10 mg
Common:
-
Increased urination
-
Genital fungal infections (especially in females)
-
Urinary tract infections (UTIs)
-
Thirst, dry mouth
-
Mild hypotension or dizziness
Rare but serious:
-
Euglycemic diabetic ketoacidosis (EDKA)
-
Fournier’s gangrene (necrotizing fasciitis of the perineum)
-
Hypotension in volume-depleted patients
-
Dehydration
Contraindications
-
Type 1 Diabetes Mellitus
-
History of diabetic ketoacidosis
-
Severe renal impairment (eGFR < 25)
-
Hypersensitivity to dapagliflozin
-
Conditions associated with lactic acidosis (e.g., severe infections, dehydration)
Drug Interactions
Drug/Class | Interaction |
---|---|
Diuretics | Additive effect on volume depletion |
Insulin/SUs | May increase hypoglycemia risk |
Lithium | Monitor levels (can affect renal clearance) |
ACE inhibitors | Monitor BP and renal function |
Monitoring Parameters
-
Blood glucose levels and HbA1c
-
Renal function (eGFR) baseline and periodically
-
Hydration status
-
Signs of UTIs or genital infections
-
Ketones if unexplained nausea, vomiting, or malaise occur
Storage Guidelines
-
Store below 25°C, in a dry place
-
Protect from light and moisture
-
Keep out of reach of children
Frequently Asked Questions (FAQs)
Q1. What is the best time to take GLIDAPAFLOZIN 10?
Anytime of day, but try to take it at the same time daily. Can be taken with or without food.
Q2. Can GLIDAPAFLOZIN 10 cause hypoglycemia?
Not by itself. However, when used with insulin or sulfonylureas, the risk increases.
Q3. Does Dapagliflozin cause weight loss?
Yes, a modest weight loss of 2–3 kg over 6 months may occur due to urinary glucose loss.
Q4. Is it safe in kidney disease?
It is not recommended in eGFR < 25 mL/min/1.73m². Renal function should be monitored regularly.
Q5. What to do if I miss a dose?
Take it as soon as remembered. If it's near the next dose, skip the missed dose. Do not double the dose.
Conclusion
GLIDAPAFLOZIN 10 offers a powerful, once-daily oral therapy for Type 2 Diabetes Mellitus, especially in patients requiring glycemic control, weight management, cardiorenal protection, or those at high cardiovascular risk. Its excellent efficacy-safety balance and convenience make it a cornerstone therapy in the modern diabetes treatment paradigm.
About The Author
Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 8209542042 , 8824175417
Recent Post

Glutathione & Vitamin C Tablets for Skin Brightening and Immunity Boost

Trelagliptin 50 mg: Dose, Uses, Side Effects & Why TRELAQWK 50 is a Smart Choice

Trelagliptin 100 mg: Uses, Dosage, Side Effects & Weekly Diabetes Control

Tolvaptan 30 mg Tablet: View Usage, Benefits, Side Effects, Precautions and Other.

Tolvaptan 15 mg Tablet: View Usage, Benefits, Side Effects, and Mechanism of Action.

Empagliflozin 25 mg – Advanced Therapy for Type 2 Diabetes Management

Tadalafil 10mg – Clinically Proven to Treat Erectile Dysfunction

Best Marine Collagen Peptides Powder With Amino Acid & Omega.

N-Acetylcysteine 600: STYLECYSTIN EF- Advanced Respiratory Support.

Glycopyrrolate IP Isotonic Solution 2ml: Understanding Glycopress